OBJECTIVE: To explore the feasibility of radical resection for cancer patients complicated with coronavirus disease 2019 (COVID-19). METHODS: The management and clinical outcome of a sigmoid cancer patient with COVID-19 were analyzed. RESULTS: The inflammation indicators and fever of this patient were effectively controlled and the lung lesions remained stable after active anti-viral treatment, then the radical colorectomy was performed after the viral negative conversion for twice. CONCLUSIONS: The case indicates that radical resection can be performed in SARS-CoV-2 patients with twice-negative SARS-CoV-2 nucleic acid testing results.
OBJECTIVE: To explore the feasibility of radical resection for cancer patients complicated with coronavirus disease 2019 (COVID-19). METHODS: The management and clinical outcome of a sigmoid cancer patient with COVID-19 were analyzed. RESULTS: The inflammation indicators and fever of this patient were effectively controlled and the lung lesions remained stable after active anti-viral treatment, then the radical colorectomy was performed after the viral negative conversion for twice. CONCLUSIONS: The case indicates that radical resection can be performed in SARS-CoV-2 patients with twice-negative SARS-CoV-2 nucleic acid testing results.
Authors: Volker Heinemann; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Ursula Vehling-Kaiser; Salah-Eddin Al-Batran; Tobias Heintges; Christian Lerchenmüller; Christoph Kahl; Gernot Seipelt; Frank Kullmann; Martina Stauch; Werner Scheithauer; Jörg Hielscher; Michael Scholz; Sebastian Müller; Hartmut Link; Norbert Niederle; Andreas Rost; Heinz-Gert Höffkes; Markus Moehler; Reinhard U Lindig; Dominik P Modest; Lisa Rossius; Thomas Kirchner; Andreas Jung; Sebastian Stintzing Journal: Lancet Oncol Date: 2014-07-31 Impact factor: 41.316
Authors: E Rebecca Longbottom; Hew D T Torrance; Helen C Owen; Paraskevi C Fragkou; Charles J Hinds; Rupert M Pearse; Michael J O'Dwyer Journal: Ann Surg Date: 2016-08 Impact factor: 12.969
Authors: Saad Alhumaid; Abbas Al Mutair; Jawad S Busubaih; Nourah Al Dossary; Murtadha Alsuliman; Sarah A Baltyour; Ibrahim Alissa; Hassan I Al Hassar; Noor A Al Aithan; Hani A Albassri; Suliman A AlOmran; Raed M ALGhazal; Ahmed Busbaih; Nasser A Alsalem; Waseem Alagnam; Mohammed Y Alyousef; Abdulaziz U Alseffay; Hussain A Al Aish; Ali Aldiaram; Hisham A Al Eissa; Murtadha A Alhumaid; Ali N Bukhamseen; Koblan M Al Mutared; Abdullah H Aljwisim; Abdullah M Twibah; Meteab M AlSaeed; Hussien A Alkhalaf; Fatemah M ALShakhs; Thoyaja Koritala; Jaffar A Al-Tawfiq; Kuldeep Dhama; Ali A Rabaan; Awad Al-Omari Journal: Infect Agent Cancer Date: 2022-09-12 Impact factor: 3.698